financetom
Business
financetom
/
Business
/
Eli Lilly to license arthritis drug to Egypt's EVA Pharma
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Eli Lilly to license arthritis drug to Egypt's EVA Pharma
Sep 4, 2024 5:51 PM

Sept 4 (Reuters) - Eli Lilly ( LLY ) and Egypt's EVA

Pharma have entered into an agreement to license Lilly's

rheumatoid arthritis drug in 49 countries in Africa, the

companies said on Wednesday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Marathon Petroleum Tops Q4 Estimates Despite Lower Refining Margins
Marathon Petroleum Tops Q4 Estimates Despite Lower Refining Margins
Feb 4, 2025
Marathon Petroleum Corporation ( MPC ) shares are trading higher after it reported fourth-quarter results. Total revenues and other income of $33.47 billion topped the consensus of $31.12 billion. Adjusted EBITDA was $2.12 billion for the quarter, compared with $3.57 billion in prior year quarter. Refining operating costs per barrel were $5.26 versus $5.55 a year ago.  Refining & Marketing refined product sales volume for the quarter was 3,747 mbpd (vs....
Westinghouse eyes old nuclear sites to build small reactors in Italy
Westinghouse eyes old nuclear sites to build small reactors in Italy
Feb 4, 2025
ROME (Reuters) - U.S. energy group Westinghouse proposed using decommissioned nuclear sites in Italy for the installation of small modular reactors, with the aim to start construction by 2030, a company official said on Tuesday. The move fits with a shift in Italy's energy policy as the right-wing government led by Prime Minister Giorgia Meloni looks to revive a sector...
McKesson Agrees to Acquire 80% Stake in PRISM Vision for $850 Million
McKesson Agrees to Acquire 80% Stake in PRISM Vision for $850 Million
Feb 4, 2025
08:33 AM EST, 02/04/2025 (MT Newswires) -- McKesson (MCK) said Tuesday it has agreed to acquire a controlling interest in PRISM Vision Holdings from Quad-C for $850 million McKesson will retain an 80% stake in the provider of ophthalmology and retina management services, while PRISM Vision physicians will hold the rest. Upon closing, PRISM Vision is anticipated to add about...
Devonian Health Reports Anti-Inflammatory Potency of Thykamine in Comparative In-Vitro Study
Devonian Health Reports Anti-Inflammatory Potency of Thykamine in Comparative In-Vitro Study
Feb 4, 2025
08:31 AM EST, 02/04/2025 (MT Newswires) -- Devonian Health Group ( DVHGF ) on Tuesday announced the results of its in-vitro study, comparing the anti-inflammatory effect of its lead candidate, Thykamine, to currently marketed anti-inflammatory agents. When compared to the other agents, Thykamine showed clinically important and statistically significant higher inhibition potency for certain cytokines that induce inflammation, a statement...
Copyright 2023-2026 - www.financetom.com All Rights Reserved